ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
12.79
+0.05 (0.43%)
At close: Nov 9, 2026, 4:00 PM EST
12.73
-0.06 (-0.44%)
After-hours: Nov 9, 2026, 6:29 PM EST

ADMA Biologics Revenue

ADMA Biologics had revenue of $141.10M in the quarter ending September 30, 2026, with 5.12% growth. This brings the company's total for the last twelve months to $519.15M, up 6.26% year-over-year. In the year 2025, ADMA Biologics had annual revenue of $510.17M with 19.63% growth. That makes ADMA Biologics the 11,059th largest company in the world by revenue and 2,267th in the United States.

Revenue (ttm)
$519.15M
Revenue Growth
+6.26%
P/S Ratio
5.47
Revenue / Employee
$802,400
Employees
647
Market Cap
2.84B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • ADMA BioManufacturing 493.00M 96.6%
  • Plasma Collection Centers 17.03M 3.3%
  • License 143.00K 0.0%

By Geography

Chart
  • United States 504.07M 98.8%
  • International 6.11M 1.2%
Fiscal year ended Dec 31, 2025 See the full ADMA Biologics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025510.17M83.72M19.63%
Dec 31, 2024426.45M168.24M65.15%
Dec 31, 2023258.22M104.14M67.59%
Dec 31, 2022154.08M73.14M90.36%
Dec 31, 202180.94M38.72M91.72%
Dec 31, 202042.22M12.87M43.85%
Dec 31, 201929.35M12.36M72.79%
Dec 31, 201816.99M-5.78M-25.37%
Dec 31, 201722.76M12.10M113.49%
Dec 31, 201610.66M3.48M48.53%
Dec 31, 20157.18M1.26M21.34%
Dec 31, 20145.92M2.85M92.84%
Dec 31, 20133.07M1.95M174.35%
Dec 31, 20121.12M357.08K46.92%
Dec 31, 2011761.04K--
Jun 30, 2011---
Dec 31, 2010---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Telix Pharmaceuticals890.79M
Arcutis Biotherapeutics508.68M
Zai Lab441.73M
Vericel324.17M
Xencor200.49M
Beam Therapeutics146.64M
Arcus Biosciences100.00M
IDEAYA Biosciences36.54M
Revenue Rankings